Vav3 oncogene activates estrogen receptor and its overexpression may be involved in human breast cancer

BMC Cancer

Volumn 8, Issue , 2008, Pages

  Lee, Kiwon ^a   Liu, Yin ^a   Mo, Jun Qin ^a   Zhang, Jinsong ^a   Dong, Zhongyun ^a   Lu, Shan ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; ESTROGEN RECEPTOR ALPHA; GLUTATHIONE TRANSFERASE; LUCIFERASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SMALL INTERFERING RNA; VAV PROTEIN; VAV3 PROTEIN; GUANINE NUCLEOTIDE EXCHANGE FACTOR; VAV3 PROTEIN, HUMAN;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL CULTURE; CANCER GROWTH; CELL DIFFERENTIATION; CELL STIMULATION; CONTROLLED STUDY; ENZYME ASSAY; GENE ACTIVATION; GENE DELETION; GENE FUNCTION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MUTATIONAL ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; BIOSYNTHESIS; BREAST TUMOR; CELL GROWTH; GENE EXPRESSION REGULATION; GENETICS; HELA CELL; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; UPREGULATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; BREAST NEOPLASMS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; EPIDERMAL GROWTH FACTOR; ESTROGEN RECEPTOR ALPHA; GENE EXPRESSION REGULATION, NEOPLASTIC; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HELA CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-VAV; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 45949098871     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-8-158     Document Type: Article

References (41)

1. Bustelo XR Regulatory and signaling properties of the Vav family Mol Cell Biol 2000, 20(5):1461-1477. 85310 10669724 10.1128/ MCB.20.5.1461-1477.2000
2. Bustelo XR Vav proteins, adaptors and cell signaling Oncogene 2001, 20(44):6372-6381. 10.1038/sj.onc.1204780 11607839
3. Katzav S Martin-Zanca D Barbacid M vav, a novel human oncogene derived from a locus ubiquitously expressed in hematopoietic cells Embo J 1989, 8(8):2283-2290. 401160 2477241
4. Zugaza JL Lopez-Lago MA Caloca MJ Dosil M Movilla N Bustelo XR Structural determinants for the biological activity of Vav proteins J Biol Chem 2002, 277(47):45377-45392. 10.1074/jbc.M208039200 12228230
5. Moores SL Selfors LM Fredericks J Breit T Fujikawa K Alt FW Brugge JS Swat W Vav family proteins couple to diverse cell surface receptors Mol Cell Biol 2000, 20(17):6364-6373. 86111 10938113 10.1128/ MCB.20.17.6364-6373.2000
6. Aghazadeh B Lowry WE Huang XY Rosen MK Structural basis for relief of autoinhibition of the Dbl homology domain of proto-oncogene Vav by tyrosine phosphorylation Cell 2000, 102(5):625-633. 10.1016/ S0092-8674(00)00085-4 11007481
7. Sommer S Fuqua SA Estrogen receptor and breast cancer Semin Cancer Biol 2001, 11(5):339-352. 10.1006/scbi.2001.0389 11562176
8. Hennessy BT Smith DL Ram PT Lu Y Mills GB Exploiting the PI3K/AKT pathway for cancer drug discovery Nature reviews 2005, 4(12):988-1004. 10.1038/nrd1902 16341064
9. Rau KM Kang HY Cha TL Miller SA Hung MC The mechanisms and managements of hormone-therapy resistance in breast and prostate cancers Endocrine-related cancer 2005, 12(3):511-532. 10.1677/erc.1.01026 16172190
10. Glaeser M Floetotto T Hanstein B Beckmann MW Niederacher D Gene amplification and expression of the steroid receptor coactivator SRC3 (AIB1) in sporadic breast and endometrial carcinomas Horm Metab Res 2001, 33(3):121-126. 10.1055/s-2001-14938 11355743
11. Rochette-Egly C Nuclear receptors: Integration of multiple signalling pathways through phosphorylation Cell Signal 2003, 15(4):355-366. 10.1016/S0898-6568(02)00115-8 12618210
12. Mills GB Lu Y Fang X Wang H Eder A Mao M Swaby R Cheng KW Stokoe D Siminovitch K Jaffe R Gray J The role of genetic abnormalities of PTEN and the phosphatidylinositol 3-kinase pathway in breast and ovarian tumorigenesis, prognosis, and therapy Semin Oncol 2001, 28(5 Suppl 16):125-141. 10.1016/S0093-7754(01)90290-8 11706404
13. Isakoff SJ Engelman JA Irie HY Luo J Brachmann SM Pearline RV Cantley LC Brugge JS Breast cancer-associated PIK3CA mutations are oncogenic in mammary epithelial cells Cancer research 2005, 65(23):10992-11000. 10.1158/0008-5472.CAN-05-2612 16322248
14. Li SY Rong M Grieu F Iacopetta B PIK3CA mutations in breast cancer are associated with poor outcome Breast Cancer Res Treat 2005, 1-5.
15. Clark AS West K Streicher S Dennis PA Constitutive and inducible Akt activity promotes resistance to chemotherapy, trastuzumab, or tamoxifen in breast cancer cells Mol Cancer Ther 2002, 1(9):707-717. 12479367
16. Ali S Coombes RC Endocrine-responsive breast cancer and strategies for combating resistance Nat Rev Cancer 2002, 2(2):101-112. 10.1038/nrc721 12635173
17. Felekkis KN Narsimhan RP Near R Castro AF Zheng Y Quilliam LA Lerner A AND-34 activates phosphatidylinositol 3-kinase and induces anti-estrogen resistance in a SH2 and GDP exchange factor-like domain-dependent manner Mol Cancer Res 2005, 3(1):32-41. 15671247
18. Guy CT Webster MA Schaller M Parsons TJ Cardiff RD Muller WJ Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease Proceedings of the National Academy of Sciences of the United States of America 1992, 89(22):10578-10582. 50384 1359541 10.1073/pnas.89.22.10578
19. Blanco-Aparicio C Perez-Gallego L Pequeno B Leal JF Renner O Carnero A Mice expressing myrAKT1 in the mammary gland develop carcinogen-induced ER-positive mammary tumors that mimic human breast cancer Carcinogenesis 2007, 28(3):584-594. 10.1093/carcin/bgl190 17050554
20. Maroulakou IG Oemler W Naber SP Tsichlis PN Akt1 ablation inhibits, whereas Akt2 ablation accelerates, the development of mammary adenocarcinomas in mouse mammary tumor virus (MMTV)-ErbB2/neu and MMTV-polyoma middle T transgenic mice Cancer research 2007, 67(1):167-177. 10.1158/0008-5472.CAN-06-3782 17210696
21. Vadlamudi RK Kumar R Functional and biological properties of the nuclear receptor coregulator PELP1/MNAR Nuclear receptor signaling 2007, 5:e004. 1876599 17525794
22. Gururaj AE Rayala SK Vadlamudi RK Kumar R Novel mechanisms of resistance to endocrine therapy: Genomic and nongenomic considerations Clin Cancer Res 2006, 12(3 Pt 2):1001s-1007s. 10.1158/1078-0432.CCR-05-2110 16467116
23. Greger JG Fursov N Cooch N McLarney S Freedman LP Edwards DP Cheskis BJ Phosphorylation of MNAR promotes estrogen activation of phosphatidylinositol 3-kinase Mol Cell Biol 2007, 27(5):1904-1913. 1820473 17194752 10.1128/MCB.01732-06
24. Wong CW McNally C Nickbarg E Komm BS Cheskis BJ Estrogen receptor-interacting protein that modulates its nongenomic activity-crosstalk with Src/Erk phosphorylation cascade Proceedings of the National Academy of Sciences of the United States of America 2002, 99(23):14783-14788. 137496 12415108 10.1073/pnas.192569699
25. Dong ZY Liu Y Lu S Wang A Lee K Wang LH Revelo M Lu S Vav3 oncogene is overexpressed and regulates cell growth and androgen receptor activity in human prostate cancer Mol Endo 2006, 20:2315-2325. 10.1210/ me.2006-0048
26. Lyons LS Burnstein KL Vav3, a Rho GTPase Guanine Nucleotide Exchange Factor, Increases During Progression to Androgen Independence in Prostate Cancer Cells and Potentiates Androgen Receptor Transcriptional Activity Mol Endocrinol 2005. December 29 16384856
27. Lu S Tsai SY Tsai MJ Melecular mechanisms of androgen-independent growth of human prostate cancer LNCaP-AI cells Endocrinology 1999, 140:5054-5059. 10.1210/en.140.11.5054 10537131
28. Zhang J Kalkum M Yamamura S Chait BT Roeder RG E protein silencing by the leukemogenic AML1-ETO fusion protein Science 2004, 305(5688):1286-1289. 10.1126/science.1097937 15333839
29. Zhang J Kalkum M Chait BT Roeder RG The N-CoR-HDAC3 nuclear receptor corepressor complex inhibits the JNK pathway through the integral subunit GPS2 Mol Cell 2002, 9(3):611-623. 10.1016/S1097-2765(02)00468-9 11931768
30. Lopez-Lago M Lee H Cruz C Movilla N Bustelo XR Tyrosine phosphorylation mediates both activation and downmodulation of the biological activity of Vav Mol Cell Biol 2000, 20(5):1678- 1691. 85351 10669745 10.1128/ MCB.20.5.1678-1691.2000
31. Tremblay A Tremblay GB Labrie F Giguere V Ligand-independent recruitment of SRC-1 to estrogen receptor beta through phosphorylation of activation function AF-1 Mol Cell 1999, 3(4):513-519. 10.1016/S1097-2765(00)80479-7 10230404
32. Yeh S Lin HK Kang HY Thin TH Lin MF Chang C From HER2/Neu signal cascade to androgen receptor and its coactivators: A novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells Proceedings of the National Academy of Sciences of the United States of America 1999, 96:5458-5463. 21881 10318905 10.1073/pnas.96.10.5458
33. Zeng L Sachdev P Yan L Chan JL Trenkle T McClelland M Welsh J Wang LH Vav3 mediates receptor protein tyrosine kinase signaling, regulates GTPase activity, modulates cell morphology, and induces cell transformation Mol Cell Biol 2000, 20(24):9212-9224. 102179 11094073 10.1128/MCB.20.24.9212-9224.2000
34. Sachdev P Zeng L Wang LH Distinct role of phosphatidylinositol 3-kinase and Rho family GTPases in Vav3-induced cell transformation, cell motility, and morphological changes J Biol Chem 2002, 277(20):17638-17648. 10.1074/jbc.M111575200 11884391
35. Houlard M Arudchandran R Regnier-Ricard F Germani A Gisselbrecht S Blank U Rivera J Varin-Blank N Vav1 is a component of transcriptionally active complexes J Exp Med 2002, 195(9):1115-1127. 2193716 11994417 10.1084/ jem.20011701
36. Movilla N Bustelo XR Biological and regulatory properties of Vav-3, a new member of the Vav family of oncoproteins Mol Cell Biol 1999, 19(11):7870-7885. 84867 10523675
37. Voegel JJ Heine MJ Tini M Vivat V Chambon P Gronemeyer H The coactivator TIF2 contains three nuclear receptor-binding motifs and mediates transactivation through CBP binding-dependent and -independent pathways Embo J 1998, 17(2):507-519. 1170401 9430642 10.1093/emboj/17.2.507
38. Leo C Chen JD The SRC family of nuclear receptor coactivators Gene 2000, 245(1):1-11. 10.1016/S0378-1119(00)00024-X 10713439
39. Tamas P Solti Z Bauer P Illes A Sipeki S Bauer A Farago A Downward J Buday L Mechanism of epidermal growth factor regulation of Vav2, a guanine nucleotide exchange factor for Rac J Biol Chem 2003, 278(7):5163-5171. 10.1074/jbc.M207555200 12454019
40. Fan P Wang J Santen RJ Yue W Long-term treatment with tamoxifen facilitates translocation of estrogen receptor alpha out of the nucleus and enhances its interaction with EGFR in MCF-7 breast cancer cells Cancer research 2007, 67(3):1352-1360. 10.1158/0008-5472.CAN-06-1020 17283173
41. Marquez DC Chen HW Curran EM Welshons WV Pietras RJ Estrogen receptors in membrane lipid rafts and signal transduction in breast cancer Molecular and cellular endocrinology 2006, 246(1-2):91-100. 10.1016/ j.mce.2005.11.020